The C1 esterase inhibitor and hereditary angioedema

This is a preview of subscription content, log in to check access.


  1. 1.

    Pensky J, Schwick HG: Human serum inhibitor of C'1 esterase: Identity with α2-neuraminoglycoprotein. Science 163:689, 1969

    Google Scholar 

  2. 2.

    Lepow IH, Ratnoff OD, Rosen FS, Pillemer L: Observations on a proesterase associated with partially purified first component of human complement (C'1). Proc Soc Exp Biol Med 92:32, 1956

    Google Scholar 

  3. 3.

    Ratnoff OD, Lepow IH: Some properties of an esterase derived from preparations of the first component of complement. J Exp Med 106:327, 1957

    Google Scholar 

  4. 4.

    Lepow IH, Ratnoff OD, Levy LR: Studies on the activation of a proesterase associated with partially purified first component of human complement. J Exp Med 107:451, 1958

    Google Scholar 

  5. 5.

    Pensky J, Levy LR, Lepow IH: Partial purification of a serum inhibitor of C'1-esterase. J Biol Chem 236:1674, 1961

    Google Scholar 

  6. 6.

    Landerman NS, Webster ME, Becker ED, Ratcliffe HE: Hereditary angioneutotic edema. II. Deficiency of inhibitor serum globulin permeability factor and/or plasma kallikrein. J Allergy 33:330, 1962

    Google Scholar 

  7. 7.

    Donaldson VH, Evans RR: A biochemical abnormality in hereditary angioneurotic edema. Am J Med 35:37, 1963

    Google Scholar 

  8. 8.

    Osler W: Hereditary angio-neurotic edema. Am J Med Sci 95:362, 1888

    Google Scholar 

  9. 9.

    Rosen FS, Charache PJ, Pensky J, Donaldson V: Hereditary angioneurotic edema: Two genetic variants. Science 148:957, 1965

    Google Scholar 

  10. 10.

    Rosen FS, Alper CA, Pensky J, Klemperer MR, Donaldson VH: Genetically determined heterogeneity of C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 50:2143, 1971

    Google Scholar 

  11. 11.

    Vaughan VC, McKay RJ, Nelson WE (eds): Textbook of Pediatrics, 10th ed. Philadelphia, W.B. Saunders, 1975, p 407

    Google Scholar 

  12. 12.

    Harpel PC, Cooper NR: Studies on human plasma C1-inactivator-enzyme interactions. I Mechanisms of interaction with C1s, plasmin and trypsin. J Clin Invest 55:593, 1975

    Google Scholar 

  13. 13.

    Haupt H, Heimburg N, Kranz T, Schnick HG: Ein Bertrag zur Isolierung and Charakterisierung des C1-Inaktivators aus Human Plasma. Eur J Biochem 17:254, 1970

    Google Scholar 

  14. 14.

    Minta JO: The role of sialic acid in the functional activity and the hepatic clearance of C1-INH. J Immunol 126:245, 1981

    Google Scholar 

  15. 15.

    Johnson AM, Alper CH, Rosen FS: C1 inhibitor—evidence for decreased hepatic synthesis in hereditary angioneurotic edema. Science 173:553, 1971

    Google Scholar 

  16. 16.

    Gadek JE, Hosea SW, Gelfand JA, Frank MM: Response of variant hereditary angioedema phenotypes to danazol therapy. J Clin Invest 64:280, 1979

    Google Scholar 

  17. 17.

    Curd JG, Yelvington M, Ziccardi R, Mathison DA, Griffin JH: Purification and characterization of two functionally distinct forms of C1 inhibitor from a patient with angioedema. Clin Exp Immunol 45:261, 1981

    Google Scholar 

  18. 18.

    Laurell AB, Martensson U: C1 inactivator protein complexed with albumin in plasma from a patient with angioneurotic edema. Eur J Immunol 1:146, 1971

    Google Scholar 

  19. 19.

    Forbes CG, Pensky J, Ratnoff OD: Inhibition of activated Hageman factor and activated thromboplastin antecedent by purified C1 inactivator. J Lab Clin Med 76:809, 1970

    Google Scholar 

  20. 20.

    Ratnoff OD, Pensky J, Ogston D, Naff GB: The inhibition of plasmin, plasma kallikrein, plasma permeability factor and the C1r subcomponent of the first component of complement by serum C1 esterase inhibitor. J Exp Med 129:315, 1969

    Google Scholar 

  21. 21.

    Schreiber AD, Kaplan AP, Austen KF: Inhibition by C1 INH of Hageman factor fragment activation of coagulation, fibrinolysis and kinin generation. J Clin Invest 52:1402, 1973

    Google Scholar 

  22. 22.

    Gigli I, Mason JW, Colman RW, Austen KF: Interaction of plasma kallikrein with the C1 inhibitor. J Immunol 104:574, 1970

    Google Scholar 

  23. 23.

    Movat HZ: Inflammation, Immunity and Hypersensitivity, Hagerstown, MD, Harper & Row, 1979, p 59

    Google Scholar 

  24. 24.

    Donaldson VH, Rosen FS: Action of complement in hereditary angioedema: The role of C1-esterase. J Clin Invest 43:2204, 1964

    Google Scholar 

  25. 25.

    Müller-Eberhard HJ: Complement. Ann Rev Biochem 44:697, 1975

    Google Scholar 

  26. 26.

    Austen KF, Sheffer AL: Detection of hereditary angioneurotic edema by demonstration of a reduction in the second component of human complement. N Engl J Med 272:649, 1965

    Google Scholar 

  27. 27.

    Donaldson VH, Rosen FS, Bing DH: Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Am Assoc Phys XL:174, 1977

    Google Scholar 

  28. 28.

    Curd JG, Prograis LJ Jr, Cochrane CA: Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. J Exp Med 152:742, 1980

    Google Scholar 

  29. 29.

    Gigli I, Ruddy S, Austen KF: The stoichiometric measurement of the serum inhibitor of the first component of complement by the inhibition of immune hemolysis. J Immunol 100:1154, 1968

    Google Scholar 

  30. 30.

    Gelfand JA, Sherins RJ, Alling DW, Frank MM: The treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med 295:1444, 1976

    Google Scholar 

  31. 31.

    Gelfand JA, Boss GR, Conley CL, Reinhart R, Frank MM: Acquired C1 esterase inhibitor deficiency and angioedema: A review. Medicine 58:321, 1979

    Google Scholar 

  32. 32.

    Sim RB, Arlaud GN, Colomb MG: Kinetics of reaction of human C1-inhibitor with the human complement system proteases Clr and Cls. Biochim Biophys Acta 612:433, 1980

    Google Scholar 

  33. 33.

    Ziccardi RJ: Activation of the early components of the classical complement pathways under physiologic conditions. J Immunol 126:1769, 1981

    Google Scholar 

  34. 34.

    Naff GB, Pensky J, Lepow IH: The macromolecular nature of the first component of human complement. J Exp Med 119:593, 1964

    Google Scholar 

  35. 35.

    Ziccardi RJ, Cooper NR: Physicochemical and functional characterization of the C1r subunit of the first complement component. J Immunol 116:496, 1976

    Google Scholar 

  36. 36.

    Sakai K, Stroud RM: Purification, molecular properties and activation of C1 proesterase, C1s. J Immunol 110:1010, 1973

    Google Scholar 

  37. 37.

    Ziccardi RJ, Cooper NR: Active disassembly of the first complement component, C1, by C1-Inactivator. J Immunol 123:788, 1979

    Google Scholar 

  38. 38.

    Sim RB, Arlaud GJ, Colomb MG: C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes. Biochem J 179:449, 1979

    Google Scholar 

  39. 39.

    Frank MM, Gelfand JA, Atkinson JP: Hereditary angioedema: The clinical syndrome and its management. Ann Intern Med 84:580, 1976

    Google Scholar 

  40. 40.

    Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM: Long term therapy of hereditary angioedema with danazol. Ann Intern Med 93:809, 1980

    Google Scholar 

  41. 41.

    Jaffe CJ, Atkinson JP, Gelfand JA, Frank MM: Hereditary angioedema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J Allergy Clin Immunol 53:386, 1975

    Google Scholar 

  42. 42.

    Gadek JE, Hosea SW, Gelfand JA, Santaella M, Wickerhauser M, Triantaphyllopoulos DC, Frank MM: Replacement therapy in hereditary angioedema. N Engl J Med 302:542, 1980

    Google Scholar 

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Frank, M.M. The C1 esterase inhibitor and hereditary angioedema. J Clin Immunol 2, 65–68 (1982).

Download citation

Key words

  • C1 esterase inhibitor
  • angioedema